Ishita Drugs Trading Window Closed for Insider Trading

Ishita Drugs & Industries Ltd has announced the closure of its trading window for designated persons. This closure is effective from Thursday, October 1, 2026, and will remain in effect for 48 hours after the declaration of the Unaudited Financial Results for the quarter ended September 30, 2026. This measure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The company has informed the stock exchange about this temporary restriction on trading securities by its key personnel to prevent potential insider trading activities.